These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2527224)

  • 41. Flucloxacillin does not achieve therapeutic cerebrospinal fluid levels against meticillin-sensitive Staphylococcus aureus in adults: A case report and review of the literature.
    Chew R; Woods ML
    Int J Antimicrob Agents; 2016 Mar; 47(3):229-31. PubMed ID: 26915477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pacemaker infections. A clinical study with special reference to prophylactic use of some isoxazolyl penicillins.
    Bluhm G
    Acta Med Scand Suppl; 1985; 699():1-62. PubMed ID: 3904338
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A mouse peritonitis model for the study of glycopeptide efficacy in GISA infections.
    Domenech A; Ribes S; Cabellos C; Domínguez MA; Montero A; Liñares J; Ariza J; Gudiol F
    Microb Drug Resist; 2004; 10(4):346-53. PubMed ID: 15650381
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
    Shibl AM; Ishag AH; Durgham SM
    APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Teicoplanin as a prophylactic antibiotic for dental bacteraemia.
    Maskell JP; Carter JL; Boyd RB; Williams RJ
    J Antimicrob Chemother; 1986 May; 17(5):651-9. PubMed ID: 2941404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experience with teicoplanin in the treatment of neonatal staphylococcal sepsis.
    Yalaz M; Cetin H; Akisu M; Yeniay B; Tunger A; Kultursay N
    J Int Med Res; 2004; 32(5):540-8. PubMed ID: 15458287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study.
    Chang HJ; Hsu PC; Yang CC; Siu LK; Kuo AJ; Chia JH; Wu TL; Huang CT; Lee MH
    J Antimicrob Chemother; 2012 Mar; 67(3):736-41. PubMed ID: 22169187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Severe infections caused by methicillin-resistant Staphylococcus aureus. 62 cases].
    May T; Janbon F; Beuscart C; Meyran M; Roue R
    Presse Med; 1993 May; 22(19):909-13. PubMed ID: 8378281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experimental studies of amoxycillin-flucloxacillin combination.
    Ripa S; Prenna M; Vitali C
    Antibiotica; 1974 Jun; 12(2):88-106. PubMed ID: 4470369
    [No Abstract]   [Full Text] [Related]  

  • 50. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
    Tarasi A; Cassone M; Monaco M; Tarasi D; Pompeo ME; Venditti M
    J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The antibacterial action of the amoxicillin-flucloxacillin combination].
    Carlone NA; Savoia D; Martinetto P
    G Batteriol Virol Immunol; 1975; 68(7-12):289-300. PubMed ID: 1234595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful treatment of right-sided native valve methicillin-resistant Staphylococcus aureus endocarditis and septicaemia with teicoplanin and rifampicin: a case report.
    Saravu K; Mukhopadhyay C; Satyanarayanan V; Pai A; Komaranchath AS; Munim F; Shastry BA; Tom D
    Scand J Infect Dis; 2012 Jul; 44(7):544-7. PubMed ID: 22385220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotic prophylaxis in cardiac surgery: serum and tissue levels of teicoplanin, flucloxacillin and tobramycin.
    Wilson AP; Taylor B; Treasure T; Grüneberg RN; Patton K; Felmingham D; Sturridge MF
    J Antimicrob Chemother; 1988 Feb; 21(2):201-12. PubMed ID: 2966139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients.
    Lemerle S; de La Rocque F; Lamy R; Fremaux A; Bernaudin F; Lobut JB; Reinert P
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():113-6. PubMed ID: 2965122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis.
    Kaatz GW; Seo SM; Dorman NJ; Lerner SA
    J Infect Dis; 1990 Jul; 162(1):103-8. PubMed ID: 2141343
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
    Schrenzel J; Harbarth S; Schockmel G; Genné D; Bregenzer T; Flueckiger U; Petignat C; Jacobs F; Francioli P; Zimmerli W; Lew DP;
    Clin Infect Dis; 2004 Nov; 39(9):1285-92. PubMed ID: 15494904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interactions of drugs acting against Staphylococcus aureus in vitro and in a mouse model.
    Renneberg J; Karlsson E; Nilsson B; Walder M
    J Infect; 1993 May; 26(3):265-77. PubMed ID: 8505561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A clinical trial on efficacy and safety of teicoplanin in combination with beta-lactams and aminoglycosides in the treatment of severe sepsis of patients undergoing allogeneic/autologous bone marrow transplantation.
    Lang E; Schmid J; Fauser AA
    Br J Haematol; 1990 Dec; 76 Suppl 2():14-8. PubMed ID: 2149045
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of a glycopeptide antibiotic, teicoplanin, in the treatment of septicaemia caused by gram-positive bacteria.
    Webster A; Wilson AP; Treasure T; Grüneberg RN
    Int J Clin Pharmacol Res; 1988; 8(2):95-8. PubMed ID: 2967800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.
    Asseray N; Jacqueline C; Le Mabecque V; Batard E; Bugnon D; Potel G; Caillon J
    Antimicrob Agents Chemother; 2005 Feb; 49(2):857-9. PubMed ID: 15673789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.